Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk.
Ozaki Y, Hong SJ, Heg D, Frigoli E, Vranckx P, Morice MC, Chevalier B, Onuma Y, Windecker S, Di Biasi M, Whitbourn R, Dudek D, Raffel OC, Shimizu K, Calabrò P, Fröbert O, Cura F, Berg JT, Smits PC, Valgimigli M. Ozaki Y, et al. Among authors: calabro p. Can J Cardiol. 2024 Sep;40(9):1671-1674. doi: 10.1016/j.cjca.2024.01.032. Epub 2024 Feb 2. Can J Cardiol. 2024. PMID: 38309468 No abstract available.
Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
Collet JP, Roffi M, Byrne RA, Costa F, Valgimigli M; Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC); ESC Scientific Document Group; Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC). Collet JP, et al. Eur Heart J. 2018 Jan 14;39(3):e1-e33. doi: 10.1093/eurheartj/ehx503. Eur Heart J. 2018. PMID: 29088328 Free article. No abstract available.
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
Rubboli A, Saia F, Sciahbasi A, Bacchi-Reggiani ML, Steffanon L, Briguori C, Calabrò P, Palmieri C, Rizzi A, Imperadore F, Sangiorgi GM, Valgimigli M, Carosio G, Steffenino G, Galvani M, Di Pasquale G, La Vecchia L, Maggioni AP, Bolognese L; WARfarin and Coronary STENTing (WAR-STENT) Study Group. Rubboli A, et al. Among authors: calabro p. J Invasive Cardiol. 2014 Nov;26(11):563-9. J Invasive Cardiol. 2014. PMID: 25363997 Free article.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators. Hiatt WR, et al. N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13. N Engl J Med. 2017. PMID: 27959717 Free article. Clinical Trial.
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators. Bhatt DL, et al. Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1. Lancet. 2019. PMID: 31484629 Free article. Clinical Trial.
Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-IT.
Moscarella E, Campo G, Leoncini M, Geraci S, Nicolini E, Cortese B, Loi B, Guiducci V, Saccà S, Varricchio A, Vicinelli P, De Candia G, Personeni D, Calabrò P, Brugaletta S, Latib A, Tespili M, Ielasi A. Moscarella E, et al. Among authors: calabro p. Cardiovasc Revasc Med. 2024 Nov 7:S1553-8389(24)00715-2. doi: 10.1016/j.carrev.2024.11.003. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39547832
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions.
Galli M, Gragnano F, Berteotti M, Marcucci R, Gargiulo G, Calabrò P, Terracciano F, Andreotti F, Patti G, De Caterina R, Capodanno D, Valgimigli M, Mehran R, Perrone Filardi P, Cirillo P, Angiolillo DJ; Working Group of Thrombosis of the Italian Society of Cardiology. Galli M, et al. Among authors: calabro p. JACC Cardiovasc Interv. 2024 Oct 28;17(20):2325-2336. doi: 10.1016/j.jcin.2024.09.011. JACC Cardiovasc Interv. 2024. PMID: 39477636 Review.
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
Gragnano F, van Klaveren D, Heg D, Räber L, Krucoff MW, Raposeiras-Roubän S, Ten Berg JM, Leonardi S, Kimura T, Corpataux N, Spirito A, Hermiller JB, Abu-Assi E, Chan Pin Yin D, Azzahhafi J, Montalto C, Galazzi M, Bär S, Kavaliauskaite R, D'Ascenzo F, De Ferrari GM, Watanabe H, Steg PG, Bhatt DL, Calabrò P, Mehran R, Urban P, Pocock S, Windecker S, Valgimigli M. Gragnano F, et al. Among authors: calabro p. Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009. Online ahead of print. Circulation. 2024. PMID: 39462482 Free article.
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions.
Galli M, Gragnano F, Berteotti M, Marcucci R, Gargiulo G, Calabrò P, Terracciano F, Andreotti F, Patti G, De Caterina R, Capodanno D, Valgimigli M, Mehran R, Perrone Filardi P, Cirillo P, Angiolillo DJ; Working Group of Thrombosis of the Italian Society of Cardiology. Galli M, et al. Among authors: calabro p. JACC Cardiovasc Interv. 2024 Oct 14;17(19):2197-2215. doi: 10.1016/j.jcin.2024.08.022. JACC Cardiovasc Interv. 2024. PMID: 39415380 Free article. Review.
517 results